ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Patient-Reported Outcomes Following the Use of Jiang Tang San Huang Tablets in Type 2 Diabetes Mellitus: A Retrospective Cohort Study in a Chinese Population

Shao, Cui; Sun, Mengxue; Liu, Wanwen; Zhao, Shaoyang; Liu, Yang; Chen, Yuna; Liang, Shu-Nung; Yuan, Haoyu; Sui, Huacheng; Wang, Baohua*; Li, Saimei*广州中医药大学; 1
DIABETES METABOLIC SYNDROME AND OBESITY-TARGET & THERAPY2022DOI: 10.2147/DMSO.S388336
20阅读
引用收藏
分享

摘要

Purpose: We aimed to assess the efficacy of the Jiang Tang San Huang (JTSH) tablet for the treatment of patients with type 2 diabetes Methods: All data for this retrospective cohort study were acquired from the outpatient clinic database of our institution, and all enrolled patients received JTSH tablet for at least two months. Overall, 147 patients were included in the analysis. The primary outcome was patient-reported outcomes on the efficacy of the JTSH tablets using a questionnaire survey. Correlation analysis evaluated the duration of JTSH tablet administration and glycemic control in patients with T2DM. The secondary outcome measures included: changes in glycated hemoglobin (HbA1c), fasting plasma glucose (FPG), 2-hour postprandial blood glucose, homeostasis model assessment of insulin resistance index (HOMA-IR) and homeostasis model assessment of I3-cell HOMA-I3) after 2 months of treatment with JTSH tablets. Results: Overall,120 patients (81.63%) reported a JTSH tablet treatment satisfaction score of >= 60 points, and believed that JTSH tablets had satisfactory hypoglycemic effects and could improve symptoms. The average duration of JTSH tablet treatment was 2.57 +/- 1.45 years. Overall, 111 patients achieved good blood glucose control, while 36 patients had poor glycemic control. Multivariate logistic regression model analysis showed that taking JTSH tablets for 1 year might reduce the risk of poor hypoglycemic effect by 17.00% (Risk ratio=0.830, 95% confidence interval:0.578, 1.021, P=0.066). Compared with the baseline data, the levels of HbA1c, FPG and HOMAIR decreased significantly and HOMA-I3 levels increased significantly (P<0.05). Conclusion: Good blood glucose control may be positively correlated with the duration of JTSH tablets administration. Patients with T2DM were satisfied with the anti-diabetic effects of JTSH tablets, which can significantly reduce blood glucose and insulin resistance, and improve the function of islet cells.

学科与关键词

关键词
type 2 diabetes mellitusJiang Tang San Huang tabletpatient-reported outcomesblood glucose controlmultiple logistic regression
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
DIABETES METABOLIC SYNDROME AND OBESITY-TARGET & THERAPY
发表日期
2022
卷期
第 15 卷
页码
4023-4033
DOI
10.2147/DMSO.S388336
成果收录
SCIE
资助标注
Fundamental and Applied Research Fund of Guangdong Province; [2021A1515220066]

作者

  • S

    Shao, Cui (第一作者)

    1 · guangzhou univ chinese med

  • S

    Sun, Mengxue

    1 · guangzhou univ chinese med

查看全部 11 位作者收起作者
  • L

    Liu, Wanwen

    1 · guangzhou univ chinese med

  • Z

    Zhao, Shaoyang

    1 · guangzhou univ chinese med

  • L

    Liu, Yang

    1 · guangzhou univ chinese med

  • C

    Chen, Yuna

    1 · guangzhou univ chinese med

  • L

    Liang, Shu-Nung

    1 · guangzhou univ chinese med

  • Y

    Yuan, Haoyu

    1 · guangzhou univ chinese med

  • S

    Sui, Huacheng

    1 · guangzhou univ chinese med

  • W

    Wang, Baohua (通讯)

    1 · guangzhou univ chinese med

  • L

    Li, Saimei (通讯)

    1 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417